Immediate Impact
1 by Nobel laureates 71 standout
Citing Papers
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
2019 Standout
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
2018 Standout
Works of A. Filiberti being referenced
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| A. Filiberti | 7448 | 2701 | 3599 | 26 | 12.2k | |
| N.K. Aaronson | 7353 | 2596 | 4282 | 23 | 13.0k | |
| M. Klee | 8275 | 2875 | 3783 | 23 | 13.5k | |
| S. Kaasa | 7152 | 2537 | 3545 | 15 | 11.9k | |
| K.C.A. Sneeuw | 7702 | 2796 | 3939 | 17 | 13.4k | |
| Fumikazu Takeda | 7332 | 2652 | 3651 | 52 | 12.2k | |
| Stewart B. Fleishman | 8788 | 2845 | 4442 | 40 | 14.5k | |
| N. Duez | 8512 | 4027 | 4448 | 49 | 14.0k | |
| Bengt Bergman | 9322 | 2925 | 5467 | 98 | 15.6k | |
| S Schraub | 8529 | 3422 | 4756 | 106 | 15.9k | |
| Hans‐Henning Flechtner | 8688 | 2985 | 4280 | 115 | 14.7k |
All Works
Loading papers...